Dialysis Patients With the Metabolic Syndrome Need Less Recombinant Human Erythropoietin for Similar Hemoglobin Levels

Add time:08/02/2019    Source:sciencedirect.com

IntroductionThe metabolic syndrome (MS) components, such as dyslipidemia, prothrombotic status, and increased blood pressure, are risk factors for patients with renal disease. Visceral fat mass is closely related to the MS and atherosclerosis. We investigated the effects of body compositions and MS on anemia parameters and recombinant human erythropoietin (rHuEPO) requirements in maintenance hemodialysis patients.

We also recommend Trading Suppliers and Manufacturers of hemoglobin F Baskent (cas 116357-59-6). Pls Click Website Link as below: cas 116357-59-6 suppliers

Prev:Fumonisins B1 + B2 change the expression of genes in apoptosis balance in Nile tilapia fingerlings
Next:Relationship of promagainin (cas 116357-66-5) to three other prohormones from the skin ofXenopus laevis: A different perspective)